Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity

European Journal of Cancer

Volumn 36, Issue 16, 2000, Pages 2146-2156

  Cho, K H ^a   Pezzuto, J M ^a,b   Bolton, J L ^b   Steele, V E ^c   Kelloff, G J ^c   Lee, S K ^b,d   Constantinou, A ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Ewha Womans University   (South Korea)

Author keywords

Carcinogenesis; Chemoprevention; Organoselenium; Predictive value; Relaxation assay; Selectivity; Specificity; Topoisomerase I; Topoisomerase II; Unknotting assay

Indexed keywords

1,2 DITHIOLE 3 THIONE DERIVATIVE; 1,4 PHENYLENE BIS(METHYLENE)SELENOCYANATE; 3 INDOLEMETHANOL; 4 AMINOBUTYRIC ACID; 4 HYDROXY 2 ETHYL 5 METHYL 3(2H) FURANONE; ANETHOLE TRITHIONE; ANTINEOPLASTIC AGENT; ASCORBIGEN; ASTAXANTHIN; CAFFEIC ACID DERIVATIVE; CAFFEIC ACID PHENETHYL ESTER; CHALCONE; DIFLUNISAL; DNA; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ELLAGIC ACID; GALANIN; GALLIC ACID; GENISTEIN; HEDERAGENIN; MADECASSOSIDE; MALTOL; NIFEDIPINE; OLEANOLIC ACID; PIROXICAM; PROTAMINE SULFATE; PROTOCATECHUIC ACID; QUERCETIN; RESVERATROL; S ALLYLCYSTEINE; SPHINGOMYELIN; SULPHORAPHANE; THIAPROLINE; UNCLASSIFIED DRUG; URSOLIC ACID;

ACCURACY; ANIMAL MODEL; ARTICLE; ASSAY; CARCINOGENESIS; CATALYSIS; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SPECIFICITY; ENZYME INHIBITION; FEMALE; HUMAN; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT;

ANIMAL; ANTICARCINOGENIC AGENTS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG SCREENING ASSAYS, ANTITUMOR; HAMSTERS; HUMAN; MICE; NEOPLASMS; RATS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033810964     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00300-2     Document Type: Article

References (41)

1. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
2. Plant-derived anticancer agents
3. Cancer chemoprevention by retinoids; animal models
4. Intermediate biomarkers of precancer and their application in chemoprevention
5. Tamoxifen for prevention of breast cancer; report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
6. Development of chemopreventive agents for lung and upper aerodigestive tract cancers
7. Recent advances in chemoprevention of cancer
8. Topoisomerase II; A specific marker for cell proliferation
9. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells
10. Novobiocin and phorbol 12-myristate 13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity
11. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models; methods and results from the NCI Chemoprevention Drug Development Program
12. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice
13. Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents
14. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein
15. Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals
16. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione(oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones
17. Chemoprevention of cancer by organoselenium compounds
18. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets
19. Strategy and planning for chemopreventive drug development; clinical development plans II
20. Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model
21. Chemoprevention of colon carcinogenesis by organosulfur compounds
22. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells
23. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids
24. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
25. Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and D-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung
26. Growth kinetics and chemoprevention of aberrant crypts in the rat colon
27. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
28. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates
29. Inhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells
30. Induction of human adenocarcinoma cell differentiation by the phytoestrogen genistein is independent to its antiestrogenic function
31. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
32. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention
33. Histone- and protamine-DNA association; conservation of different patterns within the beta-globin domain in human sperm
34. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol
35. Mechanism of inhibition of N-methyl-nitrosourea-induced mutagenicity and DNA binding by ellagic acid
36. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases; a possible mechanism for its biological activity
37. DNA and intercalating proteins in the spermiogenesis of the molluse Murex brandaris
38. Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes
39. Genistein, an inducer of tumor cell differentiation; possible mechanisms of action
40. Topoisomerase II levels during granulocytic maturation in vitro and in vivo